Skip to main content
Journal cover image

The clinical management of chondrosarcoma.

Publication ,  Journal Article
Riedel, RF; Larrier, N; Dodd, L; Kirsch, D; Martinez, S; Brigman, BE
Published in: Curr Treat Options Oncol
April 2009

Chondrosarcomas (CHS) represent a heterogeneous group of disorders ranging from indolent, low-grade tumors to aggressive, high-grade forms. Surgical resection represents the primary and preferred treatment modality for individuals with localized disease. Radiation therapy is appropriate for the treatment of positive surgical margins or palliation of disease-related symptoms. The treatment of advanced, metastatic disease is particularly challenging given the recognition that conventional chemotherapy has proven to be largely ineffective. Systemic chemotherapy may be considered in variant forms such as mesenchymal or dedifferentiated chondrosarcomas but high-quality data supporting its use is limited. There is universal agreement, however, that novel treatment strategies are desperately needed. This review will highlight the need for a coordinated multidisciplinary approach to optimize the management and care of patients.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Curr Treat Options Oncol

DOI

EISSN

1534-6277

Publication Date

April 2009

Volume

10

Issue

1-2

Start / End Page

94 / 106

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Therapies, Investigational
  • Radiotherapy, Adjuvant
  • Radiography
  • Prognosis
  • Palliative Care
  • Oncology & Carcinogenesis
  • Humans
  • Disease Management
  • Clinical Trials as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Riedel, R. F., Larrier, N., Dodd, L., Kirsch, D., Martinez, S., & Brigman, B. E. (2009). The clinical management of chondrosarcoma. Curr Treat Options Oncol, 10(1–2), 94–106. https://doi.org/10.1007/s11864-009-0088-2
Riedel, Richard F., Nicole Larrier, Leslie Dodd, David Kirsch, Salutario Martinez, and Brian E. Brigman. “The clinical management of chondrosarcoma.Curr Treat Options Oncol 10, no. 1–2 (April 2009): 94–106. https://doi.org/10.1007/s11864-009-0088-2.
Riedel RF, Larrier N, Dodd L, Kirsch D, Martinez S, Brigman BE. The clinical management of chondrosarcoma. Curr Treat Options Oncol. 2009 Apr;10(1–2):94–106.
Riedel, Richard F., et al. “The clinical management of chondrosarcoma.Curr Treat Options Oncol, vol. 10, no. 1–2, Apr. 2009, pp. 94–106. Pubmed, doi:10.1007/s11864-009-0088-2.
Riedel RF, Larrier N, Dodd L, Kirsch D, Martinez S, Brigman BE. The clinical management of chondrosarcoma. Curr Treat Options Oncol. 2009 Apr;10(1–2):94–106.
Journal cover image

Published In

Curr Treat Options Oncol

DOI

EISSN

1534-6277

Publication Date

April 2009

Volume

10

Issue

1-2

Start / End Page

94 / 106

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Therapies, Investigational
  • Radiotherapy, Adjuvant
  • Radiography
  • Prognosis
  • Palliative Care
  • Oncology & Carcinogenesis
  • Humans
  • Disease Management
  • Clinical Trials as Topic